Calithera Biosciences

Update in progress

CALA (OTC Markets OTCPK)

Company RatingNeutral
SectorFinancial Services
IndustryShell Companies

Calithera Biosciences, Inc. is operating under a plan of liquidation approved in January 2023, with remaining assets and activities being wound down under appropriate oversight. The company previously focused on clinical-stage, precision-oncology biopharmaceuticals. It was incorporated in 2010 and is headquartered in South San Francisco, California, USA.

Company score

Sentiment: 0.24; SentimentMeasures the overall tone of recent coverage and discussion about the company.−10 negative · 0 neutral · +10 positive
Environment: 0.00; EnvironmentAssesses the company’s environmental impact, risks, and sustainability practices.−10 negative · 0 neutral · +10 positive
Social: 0.18; SocialAssesses the company’s influence on employees, customers, communities, and wider society.−10 negative · 0 neutral · +10 positive
Governance: 0.13; GovernanceAssesses leadership, accountability, transparency, and business ethics.−10 negative · 0 neutral · +10 positive
Sustainability: 0.08; SustainabilityCombines environmental, social, and governance signals into an overall sustainability score.−10 negative · 0 neutral · +10 positive
Impact Score: 0.16; Impact ScoreCombines sentiment and sustainability performance into an assessment of the company’s overall impact.−10 negative · 0 neutral · +10 positive